28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes

✍ Scribed by Takashi Kadowaki; Tomoyuki Nishida; Kohei Kaku

• Book ID: 118103026
• Publisher: Wiley (Blackwell Publishing)
• Year: 2010
• Tongue: English
• Weight: 201 KB
• Volume: 1
• Category: Article
• ISSN: 2040-1116
• DOI: 10.1111/j.2040-1124.2010.00015.x